| Code | 36377 | ||||||||||
| MA number | 87/0398/06-S | ||||||||||
| Product Form: | tbl mnd 20x500 mg (fľ.HDPE) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| MAH, country: | Takeda Pharmaceuticals International AG Ireland Branch, Ireland | ||||||||||
| Therapeutic Class: | 87 - VARIA I | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | bottle HDPE | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 27.09.2006 |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Fosrenol žuvacie tablety_04.2025.pdf
|
| SPC: |
SPC_Fosrenol 500 mg žuvacie tablety_04.2025.pdf
|
| Safety feature | Yes |
| Data update: | 18.04.2023 |
